Documente Academic
Documente Profesional
Documente Cultură
Purpose: The malignancy of tumor cells can be attenuated by interfering with cell death pathways. Since hyperthermia (HT) is a very
potent radiosensitizer, the influence of HT (41.5 °C for 1 hour) alone and in combination with ionising irradiation (X-ray; 5 Gy or 10 Gy)
on the form of cell death as well as on the expression of proteins known to be major components in tumor cells’ apoptotic and necrotic
pathways were examined in colorectal tumor cells.
Material and Methods: The expression of proteins was analysed by western blot and the relative activity of caspases-3/7 by fluores-
cence-based assay. Colony formation was analysed using the clonogenic assay and cell death was determined with annexin V-FITC/prop-
idium iodide staining.
Results: Combining X-ray with HT led to similar activation of caspase-3/7 and p53 expression in comparison to irradiation only while
the amount of the pro-apoptotic proteins PUMA and Bax was increased in HCT15 and SW480 cells. HT alone or combinations with X-ray
further resulted in a temporarily increased level of the anti-apoptotic protein Bcl-2. Irradiation plus HT further led to an up-regulation of
IRF-5. The levels of RIP-1, a marker for programmed necrosis, increased in tumor cells which were treated with HT and/or X-ray. Combin-
ing 5 Gy irradiation with HT compared to irradiation resulted in a significantly increased number of necrotic tumor cells and in decreased
colony formation.
Conclusion: The combined treatment of colorectal tumor cells with X-ray and HT activates distinct tumor cell pathways and fosters the
early appearance of a necrotic tumor cell phenotype.
Kombination von ionisierender Strahlung und Hyperthermie aktiviert programmierte apoptotische und nekrotische
Zelltodessignalwege in humanen kolorektalen Tumorzellen
Hintergrund: Die Malignität von Tumorzellen kann durch Eingriffe in Zelltodeswege abgemindert werden. Da Hyperthermie (HT) strahl-
ensensibilisierend wirkt haben wir in kolorektalen Tumorzelllinien den Einfluss von HT (41.5 °C für 1 Stunde) alleine oder in Kombination
mit ionisierender Strahlung (X-ray, 5 oder 10 Gy) auf Tumorzelltodesformen und auf die Expression von Proteinen, welche Hauptbe-
standteile von apoptotischen und nekrotischen Tumorzellsignalwegen sind, untersucht.
Material und Methodik: Die Expression der Proteine wurde mit Western-Blot-Technik und die relative Aktivität von Caspasen 3/7 mit
Fluoreszenz basierendem Ansatz bestimmt. Die Koloniebildungskapazität wurde mit klonogenem Assay und Zelltod mittels AnnexinV-
FITC/Propidiumjodid Färbung ermittelt.
Ergebnisse: Kombinationen von X-ray mit HT führten zu vergleichbaren Aktivierung von Caspase 3/7 und p53-Expression im Vergleich
zur alleinigen Bestrahlung, wohingegen die Menge der pro-apoptotischen Proteine PUMA und Bax in HCT15- und SW480-Zellen zunahm.
Alleinige HT Behandlung oder Kombinationen mit X-ray resultierten in einem vorübergehend erhöhten Level an anti-apoptotischem
Protein Bcl-2. Bestrahlungen plus HT führten weiterhin zu einer Hochregulation an IRF-5. Die Mengen an RIP-1, welches ein Marker für
programmierte Nekrose darstellt, waren nach Behandlung der Tumorzellen mit HT und/oder X-ray erhöht. Die Kombination von Bestrahl-
ung mit 5Gy mit HT im Vergleich zur alleinigen Bestrahlung resultierte in einer signifikant erhöhten Anzahl an nekrotischen Tumorzellen
und einer signifikant erniedrigten Koloniebildung.
Schlussfolgerung: Kombinationsbehandlungen von kolorektalen Tumorzellen mit X-ray und HT aktivieren distinkte Tumorzelltodessig-
nalwege und fördern das rasche Auftreten eines nekrotischen Tumorzellphänotyps.
1
Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Germany,
2
Department of Radiotherapy and Oncology, University of Frankfurt, Germany.
* F. Mantel and B. Frey contributed equally to this work
Received: March 31, 2010; accepted: July 5, 2010
Published Online: November 8, 2010
SW480 HCT15
1.0 1.0
**
0.1 0.1 **
colony formation fraction
colony formation fraction
0.01 0.01
0.001 0.001
0.0001 0.0001
0.00001 0.00001
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
+ HT + HT + HT + HT
a b
Figure 1. Colony formation of SW480 and HCT15 colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The time interval
between irradiation and application of HT was 4 hours. The data are obtained from two independent experiments, each performed in duplicates. *p < 0.05,
**p < 0.01. Gy: Gray; HT: hyperthermia (41.5 °C for 1 h); w/o: untreated control.
Abbildung 1. Koloniebildung von SW480 und HCT15 kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyper-
thermie. Das Zeitintervall zwischen Bestrahlung und Hyperthermiebehandlung betrug 4 Stunden. Die Daten stammen aus zwei voneinander un-
abhängig Experimenten, welche jeweils in Duplikaten durchgeführt wurden. *p < 0.05, **p < 0.01. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde);
w/o: unbehandelte Kontrolle.
35 35
30 30
25 ** 25
20 20
15 15
** **
10 10
5 5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
+ HT + HT + HT + HT
a c
48h SW480 48h HCT15
** **
* 35 **
**
35
30
30 *
*
25
necrotic cells [%]
necrotic cells [%]
25
20
20
* 15
15
10 10 **
5 5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 2. Cell death of SW480 and HCT15 colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. Two days after
treatment of colorectal tumor cells with ionising irradiation (5 Gy or 10 Gy), HT (41.5 °C for 1 h), or a combination of both, the cells were stained
with AxV-FITC/PI, and cell death was analysed by flow cytometry. The time interval between irradiation and HT was 4 hours. The percentage of
apoptotic and necrotic tumor cells 48 hours after treatment is displayed in (a, c) and (b, d) respectively. The data are obtained from four indepen-
dent experiments, each performed in duplicate. *p < 0.05, **p < 0.01.
Abbildung 2. Zelltod von SW480 und HCT15 kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie.
Zwei Tage nach Behandlung von kolorektalen Tumorzellen mit ionisierender Bestrahlung (5 Gy oder 10 Gy), HT (41.5 °C für 1 Stunde), oder einer
Kombination aus beiden wurden die Zellen mit AxV-FITC/PI gefärbt und der Zelltod mittels durchflusszytometrischer Analyse bestimmt. Das Zei-
tintervall zwischen Bestrahlung und Hyperthermiebehandlung betrug 4 Stunden. Der Prozentsatz an apoptotischen und nekrotischen Tumorzel-
len 48 Stunden nach Behandlung ist in (a, c) bzw. (b, d) dargestellt. Die Daten stammen aus vier voneinander unabhängig Experimenten, welche
jeweils in Duplikaten durchgeführt wurden. *p < 0.05, **p < 0.01.
line, have lost one copy of chromosome 17p and thus the p53 irradiation alone or with a combination of X-ray and HT leads
gene for this allele. The remaining p53 allele is also mutated. to differences in RIP-1 (see above) or IRF-5 expression lev-
However, the tumor cells retain the proficiency for some p53 els was also studied. Interferon regulatory factors (IRF) are
functions [27]. At least 16 genes have been identified to medi- a family of transcription factors known for their role in host
ate cell death by p53 [35]. Among them, we analyzed the ex- immune response to pathogens and oncogenesis [32]. IRF-5
pression of PUMA, the p53 up-regulated modulator of apop- seems to be critical for the induction of apoptosis in response
tosis. PUMA belongs to the BH3-only proteins of the Bcl-2 to DNA damage [16]. Signalling through IRF-5 sensitizes p53-
protein family as it shows homology to the BH3 (Bcl-2 homol- deficient tumors to cell death [17] and displays a promising
ogy region) domain. It is a highly conserved protein among target for colorectal cancer therapeutics [15].
different species and has been shown to be very effective in
the induction of apoptosis [37]. Materials and Methods
The balance between pro- and anti-apoptotic proteins de- Cell Culture
cides over the cell’s determination for apoptosis or survival [7, Human colorectal adenocarcinoma SW480 cells and human
8]. We determined the expression of the effector protein Bax colorectal adenocarcinoma HCT15 cells were grown in Dul-
as a pro-apoptotic Bcl-2 family member and the expression of becco’s modified Eagle’s medium (DMEM; PAN-Biotech
the anti-apoptotic Bcl-2. In addition, whether treatment with GmbH, Aidenbach, Germany) supplemented with 10% fetal
SW480 HCT15
40 40
35 HT 35 HT
relative activity of caspase 3/7
20 10 Gy + HT 10 Gy + HT
20
15 15
10 10
5 5
0 0
a 0h 8h 24 h 32 h 48 h 72 h b 0h 8h 24 h 32 h 48 h 72 h
Figure 3. Activation of caspase-3/7 in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The activation of cas-
pase-3 and -7 in SW480 (a) or HCT15 (b) colorectal tumor cells 0, 8, 24, 32, 48 and 72 hours after single or combined treatment were analysed using a
fluorescence-based caspase activity assay. The relative caspase activity was calculated by the quotient of the activity value of the treated samples
and the activity value of the negative control (untreated cells). Both values were first corrected by subtraction of the blank value (medium without
cells). One representative set of experiments out of two is displayed. Gy: Gray; HT: hyperthermia (41.5 °C for 1 h); w/o: untreated control.
Abbildung 3. Aktivierung von Caspasen3/7 in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperther-
mie. Die Aktivierung von Caspase-3 und -7 in SW480 (a) und HCT15 (b) kolorektalen Tumorzellen 0, 8, 24, 32, 48 und 72 Stunden nach Einzel- oder
Kombinationsbehandlung wurde mit Fluoreszenz basierendem Caspase Aktivitätstest analysiert. Die relative Caspaseaktivität wurde mit dem
Quotienten des Aktivitätswertes der behandelten Probe und dem Aktivitätswert der unbehandelten Probe berechnet. Beide Werte wurden zu-
nächst durch Subtraktion des Leerwertes (Medium ohne Zellen) bereinigt. Ein repräsentatives Set von zwei Experimenten ist dargestellt. Gy: Gray;
HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
bovine serum (FBS; Biochrom AG, Berlin, Germany), 1% so- 14 days, the tumor cells were stained with methylene blue for
dium pyruvate, 2 mM glutamine, 100 U/ml penicillin, and 100 0.5 hour. Colonies greater than 50 cells were counted using an
µg/ml streptomycin at 37 °C in 5% CO2 and 90% humidity. automatic colony analyzing machine.
The cell line SW480 was obtained from the American Type
Culture Collection (ATCC; Wesel, Germany) and the HCT15 Induction and Detection of Cell Death
cells from the German Collection of Microorganisms and Cell Flow cytometry was used to detect death of colorectal tumor
Cultures (DSMZ; Braunschweig, Germany). cells after X-ray and/or HT treatment. To distinguish apop-
totic from primary and secondary necrotic cells, the exposure
Irradiation and Hyperthermia Treatment of phosphatidylserine (PS) by apoptotic and necrotic cells
A GE Inspection Technologies X-ray generator (Hürth, Ger- was analyzed by binding of FITC-labelled annexin V (AxV-
many) was used for ionising irradiation (X-ray) of the cells, FITC), and necrosis was differed from apoptosis by co-stain-
which were irradiated with a single dose of 5 Gy – average ing with propidium iodide (PI) as described previously [19]. PI
half-weekly dose in tumor therapy – (120 kV, 21.5 mA for 0.7 is able to penetrate into cells which have lost their membrane
min) or a cumulative weekly dose of 10 Gy (120 kV, 22.7 mA integrity and intercalates DNA. Analyses by flow cytometry
for 1.3 min). For hyperthermia treatment, cells were heated in were performed with an EPICS XL MCL (Coulter, Fullerton,
a HT chamber (constructed by our physicists) for 1 hour at a CA, USA) apparatus.
constant temperature of 41.5 °C. The temperature variations
which cells were exposed to were less than 0.2 °C. For cells Western Blot Analysis
treated with a combination of X-ray and HT, the time interval The intracellular amounts of p53, PUMA, Bcl-2, Bax, IRF-
between the two treatments was 4 hours. The cells were stored 5 and RIP-1 were analyzed by western blot 24 and 48 hours
at 37 °C during this time interval. after treatment. The cells were washed in ice-cold PBS and
suspended with RIPA buffer containing protease inhibitors.
Determination of Colony Formation After 30 minutes incubation on ice, the samples were centri-
The clonogenic assay was performed on single-cell suspension fuged at 13000 rpm for 8 minutes at 4 °C. The supernatants
of exponentially growing SW480 or HCT15 colorectal tumor were collected, and loading buffer was added in a ratio of 1:6.
cells. Cells were counted, plated in growth medium into Pe- The samples were then denatured at 100 °C for 10 minutes.
tri dishes, and were irradiated 12 hours after plating. After Then, 30 µg protein samples were run on a 10% or 12% SDS-
p53 p53
actin actin
4 5
(densitometric value)
(densitometric value)
3
2
2
1
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
a + HT + HT c + HT + HT
SW480 HCT15
48h 48h
p53
p53
actin actin
4 5
4
(densitometric value)
(densitometric value)
3
2
2
1
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 4. Expression of p53 in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein p53
in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 hours (b, d) after treatment with X-ray and/or HT were analysed by western blot. The
immunoblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression
of p53 in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia
(41.5 °C for 1 h); w/o: untreated control.
Abbildung 4. Expression von p53 in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an p53
Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden mit Wes-
tern Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten der Aktin-
Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von p53 der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt repräsentative
Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
PAGE and blotted to PVDF membranes (Millipore, Billerica, 10 minutes, the membranes were incubated with horse perox-
MA, USA). The membranes were blocked for at least 30 min- idase-conjugated rabbit anti-mouse (1:10,000 dilution), goat
utes with 5% non-fat dried milk in TBST and washed three anti-rabbit (1:20,000 dilution) or donkey anti-goat (1:7,500 di-
times with TBST for 10 minutes. They were incubated with lution) secondary antibody, respectively, soluted in 5% milk
the primary antibody overnight at 4 °C. The following primary in TBST for 1 hour. After washing, the membranes were incu-
antibodies were used: anti-p53 (dilution 1:2,000, Cell Signal- bated with ECL for 1 minute and then visualised using Amer-
ing), anti-PUMA (dilution 1:1,000, Cell Signaling), anti-Bcl-2 sham Hyperfilm ECL (GE Healthcare Limited, UK).
(dilution 1:200, Santa Cruz Biotechnology), anti-Bax (1:200, The densitometric values of the protein expressions ob-
Santa Cruz Biotechnology), anti-IRF-5 (dilution 1:1,000, tained by western blot analyses are displayed in the Figures
Cell Signaling) and anti-RIP-1 (dilution 1:200, Santa Cruz 4–9 and have been corrected with the actin-control expres-
Biotechnology). After washing three times with TBST for sion. The indicated protein contents were set in relation to the
actin actin
1.5 4
PUMA (18 kDa) content
(densitometric value)
3
1.0
0.5
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
+ HT + HT + HT + HT
a c
PUMA PUMA
actin actin
1.5 4
PUMA (18 kDa) content
PUMA (18 kDa) content
(densitometric value)
(densitometric value)
3
1.0
0.5
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 5. Expression of PUMA in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein PU-
MA in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 hours (b, d) after treatment with X-ray and/or HT were analysed by western blot. The
immunoblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression of
PUMA in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia (41.5
°C for 1 h); w/o: untreated control.
Abbildung 5. Expression von PUMA in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an
PUMA Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden
mit Western Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten
der Aktin-Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von PUMA der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt
repräsentative Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
expression of the proteins in untreated cells. The basal expres- and the assay reagent was added in a ratio of 1:1. The contents
sion level in untreated was set to 1. were mixed using a plate shaker at 250 rpm for 30 seconds.
The fluorescence emission was measured using a fluorescence
Analysis of Caspase-3 and -7 Activities plate reader (HTS 7000 Bio Assay Reader, Perkin Elmer)
The activities of caspase-3 and -7 were analyzed 0, 8, 24, 32, 48 with an excitation filter of 485 nm and an emission filter of 535
and 72 hours after the treatments using a fluorescence-based nm. Not only blanks containing assay reagent but also culture
caspase activity assay (Apo-ONE Homogeneous Caspase- medium without cells were used to measure the background
3/7 Assay, Promega, Madison, WI, USA). Briefly, an equal fluorescence. The latter was subtracted from the values ob-
amount of cells were given into a 96-well plate in duplicate, tained of the samples.
actin actin
2.5 2.5
2.0 2.0
(densitometric value)
(densitometric value)
Bax (23 kDa) content
1.0 1.0
0.5 0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
a + HT + HT c + HT
+ HT
actin actin
2.5 2.5
2.0 2.0
(densitometric value)
(densitometric value)
1.5 1.5
1.0 1.0
0.5 0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 6. Expression of Bax in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein Bax
in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 hours (b, d) after treatment with X-ray and/or HT were analysed by western blot. The
immunoblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression
of Bax in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia (41.5
°C for 1 h); w/o: untreated control.
Abbildung 6. Expression von Bax in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an
Bax-Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden mit
Western Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten der
Aktin-Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von Bax der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt reprä-
sentative Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
actin actin
2.5 3.0
2.0 2.5
Bcl-2 (28 kDa) content
(densitometric value)
2.0
1.5
1.5
1.0
1.0
0.5
0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
a + HT + HT c + HT + HT
bcl-2 bcl-2
actin actin
2.5 3.0
2.5
Bcl-2 (28 kDa) content
2.0
Bcl-2 (28 kDa) content
(densitometric value)
(densitometric value)
2.0
1.5
1.5
1.0
1.0
0.5 0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 7. Expression of Bcl-2 in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein Bcl-
2 in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 hours (b, d) after treatment with X-ray and/or HT were analysed by western blot. The
immunoblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression of
Bcl-2 in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia (41.5
°C for 1 h); w/o: untreated control.
Abbildung 7. Expression von Bcl-2 in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an
Bcl-2 Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden mit
Western Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten der
Aktin-Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von Bcl-2 der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt reprä-
sentative Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
X-ray Combined with Hyperthermia Induces Predomi- cells treated with HT only, X-ray alone led to a highly signifi-
nantly Necrosis in Colorectal Tumor Cells cant increase of necrotic cells after 48 hours, which could be
Colorectal SW480 and HCT 15 tumor cells behaved similar further significantly increased when combing 5 Gy irradiation
in regards to cell death induction (Figure 2). The dying tumor with HT. In addition, HT alone also resulted in a significantly
cells became secondarily necrotic instead of continuing their increased number of necrotic tumor cells. Irradiation with a
apoptotic program 2 days after treatment of SW480 (Figure 2a single dose of 10 Gy had similar effects on necrosis when com-
and b) or HCT15 (Fig. 2c and d) with X-ray and/or HT; necro- pared to irradiation plus HT. Addition of HT to 5 Gy irradi-
sis was the prominent form of cell death. For this reason, fur- ated cells produced a statistically significant increase in necro-
ther cell pathway analyses focussed on the time points 24 and sis but did not produce a statistically significant change in the
48 hours after treatment. In comparison to untreated cells or percentage of apoptotic cells.
1.5 4
(densitometric value)
(densitometric value)
3
1.0
0.5
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
+ HT + HT + HT + HT
a c
48h SW480 48h HCT15
IRF-5 IRF-5
actin actin
1.5 4
IRF-5 (60 kDa) content
IRF-5 (60 kDa) content
(densitometric value)
(densitometric value)
3
1.0
0.5
1
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 8. Expression of IRF-5 in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein IRF-5
in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 hours (b, d) after treatment with X-ray and/or HT were analysed by western blot. The
immunoblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression of
IRF-5 in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia (41.5
°C for 1 h); w/o: untreated control.
Abbildung 8. Expression von IRF-5 in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an
IRF-5 Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden mit
Western Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten der
Aktin-Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von IRF-5 der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt reprä-
sentative Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 °C für 1 Stunde); w/o: unbehandelte Kontrolle.
X-ray Combined with HT Leads to Similar Activation of and was most pronounced 48 hours after treatment for the ir-
Caspase-3 and -7 Compared to Irradiation Only radiated-only cells when comparing 5 Gy with 5 Gy plus HT.
To determine the activation of caspase-3 and -7 in colorectal In the case of irradiation with 10 Gy, the activity for caspase-
SW480 and HCT15 carcinoma cells treated with irradiation 3/7 was further increased compared to 5 Gy irradiation and
and/or HT a fluorescence-based caspase activity assay 0, 8, 24, similar in tumor cells treated with 10 Gy or 10 Gy plus HT. Af-
32, 48 and 72 hours after the respective treatments was per- ter 48 hours, the level of caspase activity reached a plateau in
formed (Figure 3a and b). After 8 hours, the different treat- SW480 cells which were irradiated or treated with irradiation
ments did not lead to an increase in caspase activity compared plus HT. In the case of HCT15 cells, the caspase-3/7 activity
to untreated cells. After 24 hours, the relative caspase activity further increased, especially with the 10 Gy dose and reached
rose showing the highest values for cells treated with X-ray a maximum after 72 hours. Cells treated with X-ray plus HT
or X-ray plus HT. The increase in caspase activity continued reached similar activity levels of caspase-3/7, 48 hours and
2.0 2.0
1.5 1.5
1.0 1.0
0.5 0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
+ HT + HT + HT + HT
a c
48h SW480 48h HCT15
RIP-1 RIP-1
actin actin
2.0 2.0
RIP-1 (74 kDa) content
(densitometric value)
1.5 1.5
1.0 1.0
0.5 0.5
0 0
w/o HT 5 Gy 5 Gy 10 Gy 10 Gy w/o HT 5 Gy 5 Gy 10 Gy 10 Gy
b + HT + HT d + HT + HT
Figure 9. Expression of RIP-1 in colorectal tumor cells after treatment with ionising irradiation and/or hyperthermia. The levels of the protein RIP-1
in SW480 and HCT15 colorectal tumor cells 24 (a, c) or 48 h (b, d) after treatment with X-ray and/or HT were analysed by western blot. The immu-
noblot bands as well as the densitometric protein expression value corrected with the actin loading control are displayed. The expression of RIP-1
in untreated cells was set to 1. The figure shows representative data from three independent experiments. Gy: Gray; HT: hyperthermia (41.5 °C for
1 h); w/o: untreated control.
Abbildung 9. Expression von RIP-1 in kolorektalen Tumorzellen nach Behandlung mit ionisierender Bestrahlung und/oder Hyperthermie. Die Menge an
RIP-1 Protein in SW480 und HCT15 kolorektalen Tumorzellen 24 Stunden (a, c) oder 48 Stunden (b, d) nach Behandlung mit X-ray und/oder HT wurden mit
Western Blot-Technik analysiert. Die Immunoblot-Banden sowie der densitometrisch ermittelte Protein Expressionslevel, welcher mit den Werten der
Aktin-Ladekontrolle korrigiert wurde, sind dargestellt. Die Expression von RIP-1 der unbehandelten Probe wurde auf 1 gesetzt. Die Abbildung zeigt reprä-
sentative Daten von drei voneinander unabhängigen Experimenten. Gy: Gray; HT: Hyperthermie (41.5 C für 1 Stunde); w/o: unbehandelte Kontrolle.
72 hours after treatment compared to irradiated only cells. HT expressed more p53 than untreated cells or cells treated with
only led to no detectable caspase-3/7 activity at all time points HT only 48 hours after the applications. HCT15 cells already
investigated. increased the p53 expression 24 hours after the respective
treatments (Figure 4c). HT only led to a slight increase in p53
X-ray Alone or Combined with HT Increases p53 expression compared to untreated cells (Figure 4b and d).
Expression in Colorectal Tumor Cells
The expression levels of p53 in SW480 or HCT15 cells 24 hours Hyperthermia and Combinations with X-ray Increases
(Figure 4a and c) and 48 hours (Figure 4b and d) after treat- Expression of PUMA
ment are displayed. Colorectal tumor cells treated with irradia- All treatments did not result in significant higher levels of PU-
tion only or treated with a combination of irradiation and HT MA in the SW480 and HCT15 tumor cells 24 hours after appli-
cation (Figure 5a and c). The expression of PUMA was gener- Discussion
ally lower in SW480 cells. 48 hours after treatment, a higher Preoperative chemoradiotherapy, as compared with postop-
level of PUMA was observed when HT was given alone or in erative chemoradiotherapy, improves local control of colorec-
combinations with X-ray in both SW480 and HCT15 tumor tal cancer [28]. Hyperthermia has been established in the
cells (Figure 5b and d). treatment of malignant diseases in combination with irradia-
tion. HT given in addition to RT significantly improved the
Hyperthermia and Combinations with X-ray Increase the number of complete responses and significant regressions in
Expression of the Pro-apoptotic Protein Bax patients with locally advanced carcinoma of the rectum and
Combinatory treatments of SW480 or HCT15 tumor cells with significantly improved the 5-year survival rates [6]. Preclini-
irradiation and hyperthermia or HT alone caused a higher ex- cal studies proved a synergy of heat with X-ray and also with
pression of the pro-apoptotic protein Bax as early as 48 hours modulated electromagnetic field in killing tumor cells [2]. In
after treatment (Figure 6). This effect was more pronounced recent years, knowledge about the immune biological mode
in SW480 cells, especially for the combinatory treatment with of action of HT is increasing. Radiosensitivity of tumor cells is
5 Gy or with HT only (Figure 6b). However, a similar tenden- often determined by the clonogenic assay. The latter defines
cy was observed for HCT15 cells (Figure 6d). the “surviving fraction” of cells treated with different radia-
tion doses. We showed that HT given in addition to X-ray (5
Hyperthermia and Combinations with X-ray Modulate Gy) significantly reduces the colony formation of SW480 and
the Expression of the Anti-apoptotic Protein Bcl-2 HCT15 cells, respectively (Figure 1). The strength of this as-
One day after treatment of SW480 colorectal tumor cells, Bcl- say is that it provides information about the percentage of tu-
2 was up-regulated in cells that had been treated with irradia- mor cell colonies that are not mitotically active. However, it
tion plus HT or HT only compared to irradiated and untreated cannot give information about the viability of the irradiated
cells (Figure 7a). In HCT15 cells, all treatments also led to an tumor cells or the type of cell death occurring since the cells
increased expression of Bcl-2 after 24 hours (Figure 7c). How- could also be senescent [20]. Therefore, AxV-FITC/PI stain-
ever, waiting for another 24 hours, the expression of Bcl-2 re- ing was applied to examine cell death of colorectal tumor cells
turned to basal levels in SW480 and HCT15 cells (Figure 7b after X-ray and/or HT treatment. Secondary necrotic cells re-
and d). sult from apoptotic cells that have lost their membrane integ-
rity while undergoing apoptosis [10]. It was shown here that
Irradiation Plus Hyperthermia Leads to Up-regulation of 48 hours after treatment with X-ray plus HT, colorectal tumor
IRF-5 cells display higher necrotic rates compared to apoptotic rates
IRF-5 sensitizes tumor cells for apoptosis. Figure 8 displays (Figure 2). HT was more potent in sensitizing tumor cells for
the level of IRF-5 in SW480 or HCT15 cells 24 and 48 hours necrosis when a lower dose of X-ray was applied. One could
after treatment. The expression levels of IRF-5 did not differ speculate that this may be a basis for the higher efficacy of HT
under all conditions 24 hours after treatment in SW480 cells when applied together with a lower total dose of RT in for
(Figure 8a). In HCT15 cells, the amount of IRF-5 was signifi- example already pre-irradiated areas [33].
cantly increased when applying HT, X-ray or combinations of We conclude that the dying colorectal SW480 and HCT15
both. After 48 hours, the combination of X-ray and HT re- cells have proceeded rather quickly into secondary necro-
sulted in a slightly higher level of IRF-5 in SW480 cells in com- sis instead of continuing their apoptotic program. The latter
parison to single treatments (Figure 8b). The total amount of was present, since prominent apoptotic proteins displayed an
IRF-5 decreased in HCT15 cells; however, all treatments led increased expression (Fig 4–6). We showed here that HT in
to an increased expression of IRF-5 in comparison to untreat- combination with X-ray fosters immune activating necrotic
ed cells (Figure 8d). cell death forms and leads to activation of apoptotic and ne-
crotic programs in tumor cells. Treatment with irradiation or
Hyperthermia, X-ray, and Combinations of Both Increase combinations of X-ray with HT lead to a higher level of p53
Expression of RIP-1 in Colorectal Tumor Cells and high activation levels of caspase-3/7 in colorectal carci-
To analyse whether treatment with X-ray and/or HT causes the noma cells.
activation of the necroptotic pathway, the expression of RIP- PUMA and Bax contribute to the activation of caspase-
1 in colorectal SW480 and HCT15 tumor cells was examined. 3/7. It was shown in this study that 48 hours after application,
After treatment, no changes were observed in both SW480 and HT given in combination with irradiation leads to a higher ex-
HCT15 cells after 24 hours (Figure 9a and c). However, after pression level of PUMA in comparison to irradiation alone.
48 hours the levels of RIP-1 increased in colorectal tumor cells Yu et al. [36] demonstrated with gene knockout (KO) experi-
which were treated with HT and/or X-ray (Figure 9b and d). ments the necessity of PUMA for apoptosis induced by p53,
A combination of irradiation and hyperthermia led to similar hypoxia and DNA-damaging agents in human colorectal can-
expression of RIP-1 in comparison to irradiation or HT alone. cer cells. PUMA functions as a de-repressor of direct activa-
tors of Bax or Bak leading to mitochondrial outer membrane
lular heat-shock proteins [24] and HMGB1 [29], contribute 19. Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cy-
tometric detection of phosphatidylserine expression on B cells undergoing
to the development of specific anti-tumor immunity. The apoptosis. Blood 1994;84:1415–20.
latter could be achieved by distinct combinatory treatments 20. Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death:
with radiotherapy, chemotherapy, HT, and further immune- recommendations of the Nomenclature Committee on Cell Death 2009. Cell
modulating agents [26]. Therefore, the analyses of molecules Death Differ 2009;16:3–11.
21. Marquardt F, Rodel F, Capalbo G, et al. Molecular targeted treatment and
involved in cell death pathways could be important predictors radiation therapy for rectal cancer. Strahlenther Onkol 2009;185:371–378.
for the success of combinatory cancer therapies. 22. Matzinger P. The danger model: a renewed sense of self. Science
2002;296:301–5.
23. Molls M. Hyperthermia–the actual role in radiation oncology and future
Acknowledgements prospects. Part I. Strahlenther Onkol 1992;168:183–190.
This work was supported by the ELAN Fond (ST-08.06.30.1) of 24. Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J
the Friedrich-Alexander University of Erlangen-Nuremberg, by the Hyperthermia 2009;25:169–75.
European Commissions (NOTE (TPA4 FP6)), and by the German 25. Nakashima T, Tanaka R, Yamashita Y, et al. Aranorosin and a novel deriva-
Research Foundation (Graduate School of the SFB 643). tive inhibit the anti-apoptotic functions regulated by Bcl-2. Biochem Bio-
phys Res Commun 2008;377:1085–90.
26. Niyazi M, Marini P, Daniel PT, et al. Efficacy of a triple treatment with irradi-
References ation, agonistic TRAIL receptor antibodies and EGFR blockade. Strahlenther
1. Adrain C, and Martin SJ. The mitochondrial apoptosome: a killer unleashed Onkol 2009;185:8–18.
by the cytochrome seas. Trends Biochem Sci 2001;26:390–7. 27. Rochette PJ, Bastien N, Lavoie J, et al. SW480, a p53 double-mutant cell line
2. Andocs G, Renner H, Balogh L, et al. Strong synergy of heat and modu- retains proficiency for some p53 functions. J Mol Biol 2005;352:44–57.
lated electromagnetic field in tumor cell killing. Strahlenther Onkol 28. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative
2009;185:120–6. chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.
3. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent 29. Schildkopf P, Frey B, Mantel F, et al. Application of hyperthermia in ad-
contribution of the immune system to anticancer chemotherapy and ra- dition to ionizing irradiation fosters necrotic cell death and HMGB1 re-
diotherapy. Nat Med 2007;13:1050–9. lease of colorectal tumor cells. Biochem Biophys Res Commun 2010;391:
4. Barzan D, Maier P, Zeller WJ, et al. Overexpression of caveolin-1 in lympho- 1014–20.
blastoid TK6 cells enhances proliferation after irradiation with clinically 30. Schildkopf P, Holmer R, Sieber R, et al. Hyperthermia in combination with
relevant doses. Strahlenther Onkol 2010;186:99–106. X-irradiation induces inflammatory forms of cell death. Autoimmunity
5. Belka C, Betsch A, Marini P, et al. [Death inducing ligands in combination 2009;42:311–3.
with ionizing radiation: objective and current knowledge]. Strahlenther 31. Sherman M, and Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci
Onkol 2003;179:141–51. 2007;1113:192–201.
6. Berdov BA, and Menteshashvili GZ. Thermoradiotherapy of patients with 32. Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription fac-
locally advanced carcinoma of the rectum. Int J Hyperthermia 1990;6: tors as regulators of host defense. Annu Rev Immunol 2001;19:623–55.
881–90. 33. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyper-
7. Budach W. [Bcl-XL and bcl-2 expression in squamous epithelial carcinomas thermia in the treatment of superficial localized breast cancer: results
of the head-neck]. Strahlenther Onkol 1999;175:533–4. from five randomized controlled trials. International Collaborative Hyper-
8. Chipuk JE, and Green DR. How do BCL-2 proteins induce mitochondrial thermia Group. Int J Radiat Oncol Biol Phys 1996;35:731–44.
outer membrane permeabilization? Trends Cell Biol 2008;18:157–64. 34. Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apop-
9. Dayanc BE, Beachy SH, Ostberg JR, et al. Dissecting the role of hyperther- totic cells. Nature 1997;390:350–1.
mia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 35. Vousden KH, and Lu X. Live or let die: the cell’s response to p53. Nat Rev
2008;24:41–56. Cancer 2002;2:594–604.
10. Gaipl US, Kuenkele S, Voll RE, et al. Complement binding is an early feature 36. Yu J, Wang Z, Kinzler KW, et al. PUMA mediates the apoptotic response
of necrotic and a rather late event during apoptotic cell death. Cell Death to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A 2003;100:
Differ 2001;8:327–34. 1931–6.
11. Galluzzi L, and Kroemer G. Necroptosis: a specialized pathway of pro- 37. Yu J, and Zhang L. No PUMA, no death: implications for p53-dependent
grammed necrosis. Cell 2008;135:1161–3. apoptosis. Cancer Cell 2003;4:248–9.
12. Golstein P, and Kroemer G. Cell death by necrosis: towards a molecular 38. Zhang P, Castedo M, Tao Y, et al. Caspase independence of radio-induced
definition. Trends Biochem Sci 2007;32:37–43. cell death. Oncogene 2006;25:7758–70.
13. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular sig-
naling network that regulates a cellular necrotic cell death pathway. Cell
2008;135:1311–23.
14. Horsman MR, and Overgaard J. Hyperthermia: a potent enhancer of radio- Address for Correspondence
therapy. Clin Oncol (R Coll Radiol) 2007;19:418–26. Priv.-Doz. Dr. Udo S. Gaipl, PhD
15. Hu G, and Barnes BJ. Interferon regulatory factor-5-regulated pathways Department of Radiation Oncology
as a target for colorectal cancer therapeutics. Expert Rev Anticancer Ther Radiation Immunobiology
2006;6:775–84.
University Hospital Erlangen
16. Hu G, and Barnes BJ. IRF-5 is a mediator of the death receptor-induced
apoptotic signaling pathway. J Biol Chem 2009;284:2767–77. Friedrich-Alexander University of Erlangen-Nürnberg
17. Hu G, Mancl ME, and Barnes BJ. Signaling through IFN regulatory factor-5 Universitätsstr. 27
sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell 91054 Erlangen
death. Cancer Res 2005;65:7403–12. Germany
18. Kerr JF, Wyllie AH, and Currie AR. Apoptosis: a basic biological phenomenon Phone: (+49) 9131-85-32311, Fax -39335
with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:
e-mail: udo.gaipl@uk-erlangen.de
239–57.